Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Autoimmune Disorders01:29

Autoimmune Disorders

1.2K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.2K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

213
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
213

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2025 update of the National French consensus on gene lists for the diagnosis of muscle diseases using high-throughput sequencing.

Journal of neuromuscular diseases·2026
Same author

Phenotype-specific muscle proteomic profiling in titinopathies.

Acta neuropathologica communications·2026
Same author

Long-term treatment outcomes of immune checkpoint inhibitor-related neuropathies: a French multicenter cohort study.

Scientific reports·2026
Same author

The Electrophysiology of Disease Remission in Chronic Inflammatory Demyelinating Polyneuropathy.

European journal of neurology·2026
Same author

Specific HLA-DRB1 Alleles Associate With Anti-Caspr1 and Anti-CNTN1 Autoantibodies in Autoimmune Nodopathies.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Restoring the interplay between the endoplasmic reticulum and mitochondria by gene therapy improves Charcot-Marie-Tooth type 2A disease.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Dec 7, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.6K

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy.

Yusuf A Rajabally1,2, Shahram Attarian3,4, Emilien Delmont3,4

  • 1Inflammatory Neuropathy Clinic, University Hospitals Birmingham, Birmingham, UK.

Journal of Inflammation Research
|September 28, 2020
PubMed
Summary
This summary is machine-generated.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a treatable autoimmune nerve disorder. Recent discoveries of antibodies to paranodal proteins offer hope for earlier diagnosis and targeted treatments in some patients.

Keywords:
chronic inflammatory demyelinating polyneuropathydysimmuneimmunologicinflammatorynodalparanodal

More Related Videos

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

9.8K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.7K

Related Experiment Videos

Last Updated: Dec 7, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.6K
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

9.8K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.7K

Area of Science:

  • Neurology
  • Immunology
  • Clinical Diagnostics

Background:

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) is a common, idiopathic autoimmune neuropathy involving cellular and humoral immunity.
  • CIDP presents in various forms, potentially due to diverse underlying mechanisms, and is treatable in most cases.
  • Diagnosis is primarily clinical, supported by electrophysiology, with cerebrospinal fluid analysis offering supplementary information.

Purpose of the Study:

  • To review the diagnostic approaches for CIDP.
  • To discuss the role of routine immunology and emerging antibody targets in CIDP diagnosis.
  • To highlight the potential impact of new discoveries on early diagnosis and management.

Main Methods:

  • Clinical diagnosis and electrophysiological assessment.
  • Cerebrospinal fluid analysis.
  • Review of current immunological diagnostic contributions and emerging antibody research in CIDP.

Main Results:

  • Routine immunology infrequently aids CIDP diagnosis but can identify associated conditions like POEMS syndrome or anti-MAG neuropathy.
  • Antibodies to paranodal proteins have been identified in a subset of CIDP patients with severe, therapy-resistant phenotypes.
  • Research indicates a high rate of antibody responses to neural structures in CIDP, suggesting future diagnostic potential.

Conclusions:

  • While diagnosis remains clinical and electrophysiological, advances in identifying specific antibodies, such as those targeting paranodal proteins, are emerging.
  • These discoveries hold promise for earlier, more accurate CIDP diagnosis and personalized treatment strategies.
  • Ensuring the reliability and reproducibility of immunologic techniques is crucial for translating these advances into clinical practice.